Efficacy evaluation of GCA treatment is primarily based on non-specific symptoms and laboratory markers. We aimed to assess the change in vascular inflammation in patients with large vessel (LV)-GCA under different treatments using [18F]FDG PET/CT.
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study / Schönau, V., Roth, J., Tascilar, K., Corte, G., Manger, B., Rech, J., Schmidt, D., Cavallaro, A., Uder, M., Crescentini, F., Boiardi, L., Casali, M., Spaggiari, L., Galli, E., Kuwert, T., Versari, A., Salvarani, C., Schett, G., Muratore, F.. - In: RHEUMATOLOGY. - ISSN 1462-0324. - 60:8(2021), pp. 3851-3861. [10.1093/rheumatology/keab332]
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study
Galli, Elena;Salvarani, Carlo;Muratore, Francesco
2021
Abstract
Efficacy evaluation of GCA treatment is primarily based on non-specific symptoms and laboratory markers. We aimed to assess the change in vascular inflammation in patients with large vessel (LV)-GCA under different treatments using [18F]FDG PET/CT.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
